Fully integrated [18F]FDG PET/MR in large vessel vasculitis.


Journal

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...
ISSN: 1827-1936
Titre abrégé: Q J Nucl Med Mol Imaging
Pays: Italy
ID NLM: 101213861

Informations de publication

Date de publication:
Sep 2022
Historique:
pubmed: 12 10 2019
medline: 8 9 2022
entrez: 12 10 2019
Statut: ppublish

Résumé

The aim of this study is to evaluate the usefulness of [ We performed an observational retrospective study based on our records. Images were acquired on a PET/MR scanner using [ Twenty-three LVV patients were included, 56.5% giant cells arteritis, 34.8% Takayasu's arteritis and 8.7% isolated aortitis, all Caucasian, mostly females (82%). We considered 32 PET scans for the LVV group (from a minimum of one to a maximum of three scans per patient) mainly during follow-up (29/32 scans), and 23 PET scans from a control group of non-metastatic malignancies patients. We found higher SUV<inf>max</inf> compared to controls, in all sites, irrespective of clinical disease activity. Mean WT resulted higher in patients than in controls but was not correlated to SUV<inf>max</inf>. Mean WT positively correlated with age in both cohorts, inversely correlated to disease duration, while no correlation with SUV<inf>max</inf> was observed. The concordance between clinically active disease and PET hypermetabolism was poor (Cohen' κ=0.33). PET/MR is a safe imaging technique capable of detecting inflammation in aortic wall. Low radiological exposure of PET/MR should be considered especially in young women receiving follow-up studies.

Sections du résumé

BACKGROUND BACKGROUND
The aim of this study is to evaluate the usefulness of [
METHODS METHODS
We performed an observational retrospective study based on our records. Images were acquired on a PET/MR scanner using [
RESULTS RESULTS
Twenty-three LVV patients were included, 56.5% giant cells arteritis, 34.8% Takayasu's arteritis and 8.7% isolated aortitis, all Caucasian, mostly females (82%). We considered 32 PET scans for the LVV group (from a minimum of one to a maximum of three scans per patient) mainly during follow-up (29/32 scans), and 23 PET scans from a control group of non-metastatic malignancies patients. We found higher SUV<inf>max</inf> compared to controls, in all sites, irrespective of clinical disease activity. Mean WT resulted higher in patients than in controls but was not correlated to SUV<inf>max</inf>. Mean WT positively correlated with age in both cohorts, inversely correlated to disease duration, while no correlation with SUV<inf>max</inf> was observed. The concordance between clinically active disease and PET hypermetabolism was poor (Cohen' κ=0.33).
CONCLUSIONS CONCLUSIONS
PET/MR is a safe imaging technique capable of detecting inflammation in aortic wall. Low radiological exposure of PET/MR should be considered especially in young women receiving follow-up studies.

Identifiants

pubmed: 31602964
pii: S1824-4785.19.03184-4
doi: 10.23736/S1824-4785.19.03184-4
doi:

Substances chimiques

Radiopharmaceuticals 0
Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

272-279

Auteurs

Roberto Padoan (R)

Unit of Rheumatology, Department of Medicine (DIMED), University of Padua, Padua, Italy - robertopadoan.reumatologia@gmail.com.

Filippo Crimì (F)

Unit of Radiology, Department of Medicine (DIMED), University of Padua, Padua, Italy.

Mara Felicetti (M)

Unit of Rheumatology, Department of Medicine (DIMED), University of Padua, Padua, Italy.

Federica Padovano (F)

Unit of Nuclear Medicine, Department of Medicine (DIMED), University of Padua, Padua, Italy.

Carmelo Lacognata (C)

Unit of Radiology, Department of Medicine (DIMED), University of Padua, Padua, Italy.

Roberto Stramare (R)

Unit of Radiology, Department of Medicine (DIMED), University of Padua, Padua, Italy.

Emilio Quaia (E)

Unit of Radiology, Department of Medicine (DIMED), University of Padua, Padua, Italy.

Diego Cecchin (D)

Unit of Nuclear Medicine, Department of Medicine (DIMED), University of Padua, Padua, Italy.
Padua Neuroscience Center, University of Padua, Padua, Italy.

Franco Bui (F)

Unit of Nuclear Medicine, Department of Medicine (DIMED), University of Padua, Padua, Italy.

Pietro Zucchetta (P)

Unit of Nuclear Medicine, Department of Medicine (DIMED), University of Padua, Padua, Italy.

Franco Schiavon (F)

Unit of Rheumatology, Department of Medicine (DIMED), University of Padua, Padua, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH